{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:19:02Z","timestamp":1761675542216},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1007\/bf02723955","type":"journal-article","created":{"date-parts":[[2007,10,16]],"date-time":"2007-10-16T06:02:47Z","timestamp":1192514567000},"page":"899-905","source":"Crossref","is-referenced-by-count":1,"title":["Prenatal diagnosis and fetal therapy-what lies in future?"],"prefix":"10.1007","volume":"67","author":[{"given":"Jill","family":"Mauldin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02723955_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1020327804500","volume":"16","author":"Y Verlinsky","year":"1999","unstructured":"Verlinsky Y. Preimplantation Diagnosis: An Alternative to Prenatal Diagosis of Genetic and Chromosomal Disorders: Report of the Eighth Annual Meeting of the International Working Group on Preimplantation Genetics in Association with the Ninth International Conference on Prenatal Diagnosis and Therapy.J Assrs Reprod Genet 1999; 16:161\u2013164.","journal-title":"J Assrs Reprod Genet"},{"key":"BF02723955_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07853899808999379","volume":"30","author":"AM Nagy","year":"1998","unstructured":"Nagy AM, De-Man X, Ruibal N, and Lints FA. Scientific and ethical issues of Preimplantation diagnosis.Ann Med 1998; 30:1\u20136.","journal-title":"Ann Med"},{"key":"BF02723955_CR3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1067\/mob.2000.104802","volume":"182","author":"FD Malone","year":"2000","unstructured":"Malone FD, Berkowitz RL, Canick JA, and D\u2019 Alton ME. First-trimester screening for aneuploidy: Research of standard of care?Am J Obstet Gynecol 2000; 182: 490\u2013496.","journal-title":"Am J Obstet Gynecol"},{"key":"BF02723955_CR4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0146-0005(99)80024-X","volume":"23","author":"Y Kitano","year":"1999","unstructured":"Kitano Y, Flake AW, Crombleholme TMet al. Open Fetal Surgery for Life-threatening Fetal Malformations.Semin Perinat 1999; 23:448\u2013461.","journal-title":"Semin Perinat"},{"key":"BF02723955_CR5","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0002-9378(97)70400-9","volume":"176","author":"GE Palomaki","year":"1997","unstructured":"Palomaki GE, Knight GJ, McCarthy JEet al. Maternal serum screening for Down syndrome in the United States: A 1995 survey.Am J Obstet Gynecol 1997; 176: 1046\u20131051.","journal-title":"Am J Obstet Gynecol"},{"key":"BF02723955_CR6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/pd.1970121112","volume":"12","author":"GE Palomaki","year":"1992","unstructured":"Palomaki GE, Knight GJ, Haddow JEet al. Prospective Intervention Trial of a Screening Protocol to Identify Fetal Trisomy 18 Using Maternal Serum Alphafetoprotein, unconjugated oestriol, and human chorionic gonadotropin.Prenat Diag 1992; 12: 925\u2013930.","journal-title":"Prenat Diag"},{"key":"BF02723955_CR7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0002-9378(98)70198-X","volume":"176","author":"KD Wenstrom","year":"1998","unstructured":"Wenstrom KD, Chu DC, Own J and Boots L. Maternal serum alpha-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome.Am J Obstet Gynecol 1998; 176: 966\u201370.","journal-title":"Am J Obstet Gynecol"},{"key":"BF02723955_CR8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000020816","volume":"13","author":"R Zanini","year":"1998","unstructured":"Zanini R, Tarantini M, Cerri Vet al. \u201cDual positivity\u201d for neural tube defects and Down syndrome at maternal serum screening: gestational outcome.Fetal Diag Therapy 1998; 13 :106\u2013110.","journal-title":"Fetal Diag Therapy"},{"key":"BF02723955_CR9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0002-9378(91)90289-4","volume":"165","author":"B Crandall","year":"1991","unstructured":"Crandall B, Robinson L and Grau P. Risks associated with an elevated maternal serum a-fetoprotein level.Am J Obstet Gynecol 1991; 165: 581\u2013586.","journal-title":"Am J Obstet Gynecol"},{"key":"BF02723955_CR10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJM199107043250102","volume":"325","author":"K Waller","year":"1991","unstructured":"Waller K, Lustig LS, Cunningham GCet al. Secondtrimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death.N Engl J Med 1991; 325:6\u201310.","journal-title":"N Engl J Med"},{"key":"BF02723955_CR11","first-page":"83","volume":"80","author":"R Gonen","year":"1992","unstructured":"Gonen R, Perez R, David Met al. The Association Between Unexplained Second-Trimester Maternal Serum hCG Elevation and Pregnancy Complications.Obstet Gynecol 1992; 80: 83\u201386.","journal-title":"Obstet Gynecol"},{"key":"BF02723955_CR12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0002-9378(99)70334-0","volume":"181","author":"Y Yaron","year":"1999","unstructured":"Yaron Y, Cherry M, Kramer Ret al. Second-trimester 1 maternal serum marker screening: Maternal serum afetoprotein, P-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.Am J Obstet Gynecol 1999; 181:968\u2013974.","journal-title":"Am J Obstet Gynecol"},{"key":"BF02723955_CR13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0146-0005(99)80002-0","volume":"23","author":"JA Canick","year":"1999","unstructured":"Canick JA and Kellner LH. First Trimester Screening for Aneuploidy: Serum Biochemical Markers.Semin Perinatol 1999; 23 :359\u2013368.","journal-title":"Semin Perinatol"},{"key":"BF02723955_CR14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/096914139700400402","volume":"4","author":"NJ Wald","year":"1997","unstructured":"Wald NJ, Kennard A, Hackshaw Aet al. Antental screening for Down\u2019s syndrome.J. Med Screening 1997; 4:181\u2013246.","journal-title":"J. Med Screening"},{"key":"BF02723955_CR15","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/0002-9378(93)90703-L","volume":"168","author":"BF Grandall","year":"1993","unstructured":"Grandall BF, Hanson FW, Keener Set al. Maternal serum screening for alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of pregnancy to detect chromosomal abnormalities.Am J Obstet Gynecol 1993; 168:1864\u20131869.","journal-title":"Am J Obstet Gynecol"},{"key":"BF02723955_CR16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-0528.1996.tb09765.x","volume":"103","author":"NJ Wald","year":"1996","unstructured":"Wald NJ, George L, Smith Det al. The International Prenatal Screening Research Group: Serum screening for Down\u2019s syndrome between 8 and 14 weeks of pregnancy.Br. J Obstet Gynaecol 1996; 103 : 407\u2013412.","journal-title":"Br. J Obstet Gynaecol"},{"key":"BF02723955_CR17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM199804023381404","volume":"338","author":"JE Haddow","year":"1998","unstructured":"Haddow JE, Palomaki GE, Knight GJet al. Screening of maternal serum for fetal Down\u2019s syndrome in the first trimester.N Engl J Med 1998; 338: 955\u2013961.","journal-title":"N Engl J Med"},{"key":"BF02723955_CR18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0002-9378(96)70436-2","volume":"174","author":"DA Krantz","year":"1996","unstructured":"Krantz DA, Larsen JW, Buchanan PD, Macri JN. First trimester Down syndrome screening; free beta human chorionic gonadotropin and pregnancy-associated plasma protein A.Am J Obstet Gynecol 1996; 174: 612\u2013616.","journal-title":"Am J Obstet Gynecol"},{"key":"BF02723955_CR19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1471-0528.1997.tb12025.x","volume":"104","author":"E Berry","year":"1997","unstructured":"Berry E, Aitken DA, Crossley JAet al. Sceening for Down\u2019s syndrome: Changes in markers levels and detection rates between first and second trimester.Br J Obstet Gynaecol 1997; 104 : 811\u2013817.","journal-title":"Br J Obstet Gynaecol"},{"key":"BF02723955_CR20","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1471-0528.1998.tb10239.x","volume":"105","author":"R Biagiotti","year":"1998","unstructured":"Biagiotti R, Brizzi L, Periti E, d\u2019Agata A, Vanzi E, Cariata E. First trimester Screening for Down\u2019s syndrome using maternal serum PAPP-A and free beta-hCG in combination with fetal nuchal translucency thickness.Br J Obstet Gynaecol 1998; 105: 917\u2013920.","journal-title":"Br J Obstet Gynaecol"},{"key":"BF02723955_CR21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0146-0005(99)80003-2","volume":"23","author":"TL Stewart","year":"1999","unstructured":"Stewart TL and Malone FD. First trimester screening for aneuploidy: nuchal translucency sonography.Semin Perinato 1999; 23: 369\u2013381.","journal-title":"Semin Perinato"},{"key":"BF02723955_CR22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1471-0528.1995.tb11290.x","volume":"102","author":"S Bewley","year":"1995","unstructured":"Bewley S, Roberts LJ, Mackinson AM and Rodeck CH. First trimester fetal nuchal translucency: problems with screening the general population.Br J Obstet Gynecol 1995; 102:386\u2013388.","journal-title":"Br J Obstet Gynecol"},{"key":"BF02723955_CR23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/(SICI)1097-0223(199609)16:9<797::AID-PD948>3.0.CO;2-M","volume":"16","author":"LH Kornman","year":"1996","unstructured":"Kornman LH, Morssink LP, Beekhuis JRet al. Nuchal translucency cannot be used as a screening test for chromosomal abnormalities in the first trimester of pregnancy in a routine ultrasound practice.Prenat Diagn 1996; 16:797\u2013805.","journal-title":"Prenat Diagn"},{"key":"BF02723955_CR24","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1056\/NEJM199712043372303","volume":"337","author":"P Taipale","year":"1997","unstructured":"Taipale P, Hiilesmaa V, Salonen R, Ylostalo P. Increased nuchal translucency as a marker for fetal chromosmal defects.N Engl J Med 1997; 337:1654\u20131658.","journal-title":"N Engl J Med"},{"key":"BF02723955_CR25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1097-0223(199801)18:1<29::AID-PD213>3.0.CO;2-N","volume":"18","author":"E Hafner","year":"1998","unstructured":"Hafner E, Schuchter K, Liebhart E, Philipp K. Results of routine fetal nuchal translucency measurement at weeks 10-13 in 4233 unselected pregnant women.Prenat Diagn 1998; 18: 29\u201334.","journal-title":"Prenat Diagn"},{"key":"BF02723955_CR26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1469-0705.1997.10060381.x","volume":"10","author":"F Orlandi","year":"1997","unstructured":"Orlandi F, Damiani G, Hallahan TW et al. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.Ultrasound Obstet Gynecol 1997; 10: 381\u2013386.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"BF02723955_CR27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1469-0705.1998.12030163.x","volume":"12","author":"E Pajkrt","year":"1998","unstructured":"Pajkrt E, Van Uth JM, Mol BWet al. Screening for Down\u2019s syndrome by fetal nuchal translucency measurement in a general obstetric population.Ultrasound Obstet Gynecol 1998; 12:163\u2013169.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"BF02723955_CR28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/(SICI)1097-0223(199802)18:2<133::AID-PD236>3.0.CO;2-O","volume":"18","author":"P Theodoropoulos","year":"1998","unstructured":"Theodoropoulos P, Lolis D, Papageorgiou Cet al. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.Prenat Diagn 1998; 18: 133\u2013137.","journal-title":"Prenat Diagn"},{"key":"BF02723955_CR29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(97)11280-6","volume":"351","author":"RJ Snijders","year":"1998","unstructured":"Snijders RJ, Noble P, Sebire Net al. UK multicenter project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation.Lancet 1998; 351: 343\u2013346.","journal-title":"Lancet"},{"key":"BF02723955_CR30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0140-6736(98)22031-9","volume":"351","author":"JE Haddow","year":"1998","unstructured":"Haddow JE. Antenatal screening for Down\u2019s syndrome: where are we and where next ?Lancet 1998; 351:336\u2013337.","journal-title":"Lancet"},{"key":"BF02723955_CR31","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.0.CO;2-5","volume":"17","author":"NJ Wald","year":"1997","unstructured":"Wald NJ, Hackshaw AK. Combining ultrasound and biochemistry in first-trimester screening for Down\u2019s syndrome.Prenat Diagn 1997; 17: 821\u2013829.","journal-title":"Prenat Diagn"},{"key":"BF02723955_CR32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/(SICI)1097-0223(199904)19:4<360::AID-PD556>3.0.CO;2-U","volume":"19","author":"P Biasio De","year":"1999","unstructured":"De Biasio P, Siccardi M, Volpe Get al. First-trimester screening for Down syndrome using nuchal tranclucency measurement with free beta-hCG and PAPP-A between 10 and 13 weeks of pregnancy-the combined test.Prenat Diagn 1999; 19: 360\u2013363.","journal-title":"Prenat Diagn"},{"key":"BF02723955_CR33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1469-0705.1999.13040231.x","volume":"13","author":"K Spencer","year":"1999","unstructured":"Spencer K, Souter V, Tul Net al. A screening programme for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free (3-human chorionic gonadotropin and pregnancy-associated plasma protein-A.Ultrasound Obstet Gynecol 1999; 13: 231\u2013237.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"BF02723955_CR34","volume-title":"First Trimester Screening for Fetal Anomalies with Nuchal Translucency","author":"American College of Obstetricians and Gynecologists","year":"1999","unstructured":"American College of Obstetricians and Gynecologists.First Trimester Screening for Fetal Anomalies with Nuchal Translucency. ACOG Commitee Opinion 223. Washington, DC: ACOG, 1999."},{"key":"BF02723955_CR35","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1001\/jama.1989.03430200091032","volume":"262","author":"A Milunsky","year":"1989","unstructured":"Milunsky A, Jick H, Jick Set al. Multivitamin\/folk acid supplementation in early pregnancy reduces the prevalence of neural tube defects.JAMA 1989; 262: 2847\u20132852.","journal-title":"JAMA"},{"key":"BF02723955_CR36","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0146-0005(99)80025-1","volume":"23","author":"O Olutoye","year":"1999","unstructured":"Olutoye O and Adzick S. Fetal Surgery for Myelomeningocele.Semin Perintol 1999; 23: 462\u2013473.","journal-title":"Semin Perintol"},{"key":"BF02723955_CR37","first-page":"15","volume":"25","author":"BW Paek","year":"2000","unstructured":"Paek BW, Harrison M, Albanese CT, Farmer DL. Advances in Fetal Surgery: Prenatal Repair of Myelomeningocele.The Female Patient 2000; 25 :15\u201319.","journal-title":"The Female Patient"},{"key":"BF02723955_CR38","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.282.19.1819","volume":"282","author":"JP Bruner","year":"1999","unstructured":"Bruner JP, Tulipan N, Paschall RLet al. Fetal surgery for myelomeningocele and the incidence of shuntdependent hydrocephalus.JAMA 1999; 282:1819\u20131835.","journal-title":"JAMA"},{"key":"BF02723955_CR39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0002-9378(99)70167-5","volume":"180","author":"JP Bruner","year":"1999","unstructured":"Bruner JP, Richards WO, Tulipan NB, Arney TL. Endoscopic coverage of fetal myelomeningocele in utero.Am J Obstet Gynecol 1999; 180: 153\u2013158.","journal-title":"Am J Obstet Gynecol"},{"key":"BF02723955_CR40","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(98)00070-1","volume":"352","author":"NS Adzick","year":"1998","unstructured":"Adzick NS, Sutton LN, Crombleholme TM, Flake AW. Successful fetal surgery for spina bifida.Lancet 1998; 352:1675\u20131676.","journal-title":"Lancet"},{"key":"BF02723955_CR41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0146-0005(99)80005-6","volume":"5","author":"B Pertl","year":"1999","unstructured":"Pertl B and Bianchi DW. First Trimester Prenatal Diagnosis: Fetal Cells in the Maternal Circulation. Semin Perinatol. 1999; 5: 393\u2013402.","journal-title":"Semin Perinatol."},{"key":"BF02723955_CR42","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1086\/514885","volume":"61","author":"DW Biachi","year":"1997","unstructured":"Biachi DW, Williams JM, Sullivan LMet al. PCR quantification of fetal cells in maternal blood in normal and aneuploid pregnancies.Am J Hum Genet 1997; 61: 822\u2013829.","journal-title":"Am J Hum Genet"},{"key":"BF02723955_CR43","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1001\/jama.1993.03510190113036","volume":"270","author":"JL Simpson","year":"1993","unstructured":"Simpson JL, Elias S. Isolating fetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology.J Am Med Assoc 1993; 270: 2357\u20132361.","journal-title":"J Am Med Assoc"},{"key":"BF02723955_CR44","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0140-6736(94)90158-9","volume":"343","author":"D Gaenshirt","year":"1994","unstructured":"Gaenshirt D, Garritsen HSP, Miny Pet al. Fetal cells in maternal circulation throughout gestation.Lancet 1994; 343:1038\u20131039.","journal-title":"Lancet"},{"key":"BF02723955_CR45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1096-8628(20000424)91:5<331::AID-AJMG2>3.0.CO;2-S","volume":"91","author":"A Farina","year":"2000","unstructured":"Farina A, Malone FD, and Bianchi DW. Fetal Sonographic Findings: Analysis of the Most Frequent Patterns and Their Specificity of Association.Am J Med Genet 2000; 91 : 331\u2013339.","journal-title":"Am J Med Genet"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02723955.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02723955\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02723955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T02:02:41Z","timestamp":1558231361000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02723955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["BF02723955"],"URL":"https:\/\/doi.org\/10.1007\/bf02723955","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}